Search Results - "Taniyama, Tomohiko"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Incidence and associated factors of sudden unexpected death in advanced cancer patients: A multicenter prospective cohort study by Ito, Satoko, Morita, Tatsuya, Uneno, Yu, Taniyama, Tomohiko, Matsuda, Yosuke, Kohara, Hiroyuki, Maeda, Isseki, Nakayama, Takeo, Mori, Masanori

    Published in Cancer medicine (Malden, MA) (01-07-2021)
    “…Purpose A sudden unexpected death has significant negative impacts on patients, family caregivers, and medical staff in hospice/palliative care. This study…”
    Get full text
    Journal Article
  3. 3

    “3‐Day Surprise Question” to predict prognosis of advanced cancer patients with impending death: Multicenter prospective observational study by Ikari, Tomoo, Hiratsuka, Yusuke, Yamaguchi, Takuhiro, Maeda, Isseki, Mori, Masanori, Uneno, Yu, Taniyama, Tomohiko, Matsuda, Yosuke, Oya, Kiyofumi, Tagami, Keita, Inoue, Akira

    Published in Cancer medicine (Malden, MA) (01-02-2021)
    “…Background The study aimed to clarify the efficacy of the “3‐Day Surprise Question (3DSQ)” in predicting the prognosis for advanced cancer patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Risk factors of sudden unexpected death in patients with advanced cancer near the end of life by Taniyama, Tomohiko, Tokutani, Rie, Hiramoto, Shuji

    Published in Palliative & supportive care (01-12-2022)
    “…The definition of sudden unexpected death (SUD) in patients with advanced cancer near the end of life (EOL) was unclear. This study was conducted as a…”
    Get more information
    Journal Article
  7. 7

    The frequency and predictors of end-of-life symptom in patients with advanced cancer by Hiramoto, Shuji, Kikuchi, Ayako, Taniyama, Tomohiko, Tetsuo, Hori, Yoshioka, Akira, Kirishima, Toshihiko

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e24061 Background: Advanced cancer patients complain of highly distressing symptom at the end-of-life, and important reasons for palliative…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life by Hiramoto, Shuji, Taniyama, Tomohiko, Kikuchi, Ayako, Hori, Tetsuo, Yoshioka, Akira, Inoue, Akira

    Published in Palliative & supportive care (01-12-2021)
    “…In recent years, the use of both molecular targeting agents (MTAs) and immune-checkpoint inhibitors (ICIs) tend to occupy important positions in systemic…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14